Search
for
Sort by
Research 631–660 of 1000+
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Treatment of Alopecia Areata With Tofacitinib
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Signaling in the stem cell niche: regulating cell fate, function and plasticity
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Ritlecitinib in severe alopecia areata: a profile of its use
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture